Hepatitis C: The dermatologic profile

Journal of Pakistan Association of Dermatologists

Volumn 18, Issue 3, 2008, Pages 171-181

  Muzaffar, Farhana ^a   Hussain, Ijaz ^b   Haroon, Tahir Saeed ^c  

^a CHILDREN S HOSPITAL   (Pakistan)

^b Ameeruddin Medical College PGMI Lahore General Hospital M Phil Stud   (Pakistan)

^c MAYO HOSPITAL   (Pakistan)

Author keywords

Dermatologic profile; Hepatitis C; Skin manifestations

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN;

ACTINIC POROKERATOSIS; ALOPECIA AREATA; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; BEHCET DISEASE; CHRONIC HEPATITIS; CRYOGLOBULINEMIA; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE TRANSMISSION; DRUG ERUPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA MULTIFORME; ERYTHEMA NODOSUM; GRANULOMA ANNULARE; HEMANGIOMA; HEPATITIS C; HUMAN; IMMUNE SYSTEM; LICHEN PLANUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PAKISTAN; PATHOGENESIS; PLASMACYTOMA; POLYARTERITIS NODOSA; PORPHYRIA CUTANEA TARDA; PREVALENCE; PROGNOSIS; PRURITUS; PSORIASIS; PYODERMA GANGRENOSUM; REVIEW; RISK ASSESSMENT; SCREENING; SEROLOGY; SIALOADENITIS; SKIN DISEASE; SKIN MANIFESTATION; THROMBOCYTOPENIA; TREATMENT RESPONSE; URTICARIA; VASCULITIS; VERRUCOUS CARCINOMA; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS TRANSMISSION; VITILIGO;

EID: 77950830658     PISSN: 15609014     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. WHO. Hepatitis C [internet]. Geneva: WHO. C2004 [cited 15.07.2008]. Available from: http//www.who.int/mediacentre/factssheets/fs164/en/.
2. Bonkovsky HL, Mehta S, Hepatitis C: A review and update. J Am Acad Dermatol 2001; 44: 159-79.
3. Maticic M. Hepatitis C virus infection: the dermatological perspective. Acta Dermatoven APA 2003; 12: 19-27. (Pubitemid 36402439)
4. Chung CM, Nunley JR. Overview of hepatitis C and skin. Dermatol Nurs 2006; 18: 425-30.
5. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nature Rev Immunol 2004: 5: 215-9. (Pubitemid 40364823)
6. Schwartz RA, Birnkrant AP. Cutaneous manifestations of hepatitis C. Available from www.emedicine.com/derm/hepatitisC. Accessed on 17.02.2008.
7. Mohsin A. Pakistan: a cirrhotic state in need of a savior! (editorial). Esculapio 2006; 2: 1.
8. Idrees M, Riazuddin S. Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Infect Dis 2008; 8: 69. (Pubitemid 351803135)
9. Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008; 41: 4-8. (Pubitemid 351792115)
10. Chaudhary IA, Samiullah, Khan SS et al. Seroprevalence of hepatitis B and C among the healthy blood donors at Fauji Foundation Hospital, Rawalpindi. Pak J Med Sci 2007; 23: 64-7. (Pubitemid 46409580)
11. Jehangir W, Ali F, Shahnawaz U et al. Prevalence of hepatitis B, C and HIV in blood donors of South Punjab. Esculapio 2006; 2: 6-7.
12. Muhammad N, Jan A. Frequency of hepatitis C in Buner, NWFP. J Coll Physicians Surg Pak 2005; 15: 11-4.
13. Khokhar N, Gill ML, Malik GA. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Physicians Surg Pak 2004; 14: 534-6. (Pubitemid 39341726)
14. Kazmi K, Sadaruddin A, Dil AS, Zuberi SJ. Prevalence of HCV in blood donors. Pak J Med Res 1997; 36: 61-2.
15. Khan MSA, Khalid M, Ayub N, Javed M. Seroprevalence and risk factors of Hepatitis C virus (HCV) in Mardan, N.W.F.P. Rawal Med J 2004; 29: 57-60.
16. Hashmie ZY, Chaudhary AH, Ahmad M, Ashraf M. Incidence of anti-hepatitis C virus positivity in healthy voluntary blood donors at Faisalabad. Professional 1999; 6: 551-5.
17. Tariq W, Hussain AB, Karamat KA et al. Demographic aspects of hepatitis C in Northern Pakistan. J Pak Med Assoc 1999; 49: 198-201.
18. Shamsi T, Ahmad A, Taj Z. Prevalence of hepatitis B, C and HIV virus infection among beta thalassaemia major patients. Pak J Med Res 1998; 48: 87.
19. Fayyaz H, Latif Y, Sohail R, Zaman F. Screening for hepatitis C in gynecological population. Ann King Edward Med Coll 2004; 10: 287-8.
20. Hakeem A, Khan MS, Abdullah M et al. Prevalence of HBs & anti-HCV in pregnant ladies attending antenatal clinic at Sheikh Zayed Medical Complex, Rahim Yar Khan. Esculapio 2006; 2: 8-10.
21. Idrees M, Lal A, Naseem M, Khalid M. High prevalence of hepatitis C virus infection in the largest province of Pakistan. J Dig Dis 2008; 9: 95-103. (Pubitemid 351566631)
22. Foster G, Mathurin P. Hepatitis C virus therapy to date. Antivir Ther 2008; 13 Suppl 1: 3-8. (Pubitemid 351542492)
23. Azafar NA, Zaman T, Rashid T, Jahangir M. Cutaneous manifestations in patients of hepatitis C. J Pak Assoc Dermatol 2008; 18: 138-43.
24. Dervis E, Serez K. The prevalence of dermatologic manifestations related to chronic hepatitis C virus infection in a study from a single center in Turkey. Acta Dermatoven APA, 2005; 14: 93-8. (Pubitemid 41291370)
25. Paoletti V, Mammarella A, Basili S et al. Prevalence and clinical features of skin disease in chronic hepatitis C infection. A prospective study in 96 patients. Panmineva Med 2002; 44: 349-52. (Pubitemid 41328280)
26. deSanjose S, Benavente Y, Vajdic CM et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-8. (Pubitemid 351447318)
27. Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994; 31: 1070-2. (Pubitemid 24365059)
28. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Inv 1995; 25: 910-4. (Pubitemid 26025703)
29. Grote M, Reichart PA, Berg T, Hops U. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol 1998; 29: 1034-5. (Pubitemid 28559081)
30. Shahid M. HCV seropositivity in patients with lichen planus (dissertation for fellowship). Karachi: College of Physicians and Surgeons Pakistan; 2003.
31. Mignogna MD, Muzio LL, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998; 37: 575-8. (Pubitemid 28389316)
32. Maticic M, Poljak M, Kramar B et al. Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva. J Periodontol 2001; 72: 11-16. (Pubitemid 33607779)
33. Divano MC, Prodi A, Rebora A. Anti-GOR antibodies in lichen planus. Dermatology 1994; 188: 205-6. (Pubitemid 24055317)
34. Abdallah MA, Ghozzi MY, Monib HA et al. Necrolytic acral erythema: A cutaneous sign of hepatitis C virus infection. J Am Acad Dermatol 2005: 53: 247-51.
35. Hivnor CM, Yan AC, Junkins-Hopkins JM, Honig PJ. Necrolytic acral erythema: Response to combination therapy with interferon and ribavirin. J Am Acad Dermatol 2004; 50: S121-4.
36. Cribier BJ, Santinelli F, Schmitti C et al. Chronic urticaria is not significantly associated with hepatitis C virus or hepatitis G virus infection: a case control study. Arch Dermatol 1999; 135: 1335-9.
37. Kanazawa K, Yaoita H, Tsuda F, Okamoto H. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996; 35: 195-8. (Pubitemid 26260244)
38. Ahmed I, Wahid Z, Ahmed Z. Chronic urticaria: frequency of anti-HCV antibodies. J Pak Assoc Dermatol 2003; 13: 179-83. (Pubitemid 38252485)
39. Malik LM, Mufti S, Saeed S et al. Hepatitis C seropositivity in patients with acute and chronic urticaria. J Pak Assoc Dermatol 2008; 18: 144-8.
40. Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Dis 2008; 14: 123-30. (Pubitemid 351301053)
41. Jackson JM, Callen JP. Scarring alopecia and sclerodermatous changes of the scalp in a patient with hepatitis C infection. J Am Acad Dermatol 1998; 39: 824-6.
42. D'Alessandro-Gandolfo L, Biocaiti G, Griso D, Marci A, Topi G. Frequency of viral hepatitis markers in porphyria cutanea tarda. Eur J Dermatol 1993; 3: 180-2. (Pubitemid 23161841)
43. Navas S, Bosch O, Castillo I, Marriott E, Carreno V. Porphyria cutanea tarda and hepatitis C and B virus infection: a retrospective study. Hepatology 1995; 21: 279-84.
44. Aamir S, Ullah Z, Iqbal Z, Khan AA, Yaqub F, Malik K. Cutaneous manifestations of interferon alfa and ribavirin for hepatitis C. J Pak Assoc Dermatol 2008; 18: 14-20.
45. Takeshi Kono T, Kobayashi H, Masamitsu Ishii M et al. Synchronous development of disseminated superficial porokeratosis and hepatitis C virusrelated hepatocellular carcinoma. J Am Acad Dermatol 2000; 43: 966-8.
46. Ota M, Sato-Matsumura KC, Sawamura D, Shimizu H. Papuloerythroderma associated with hepatitis C virus infection. J Am Acad Dermatol 2005; 5: S61-2. (Pubitemid 40164770)
47. Granel B, Serratrice J, Rey J et al. Chronic hepatitis C virus infection associated with a generalized granuloma annulare. J Am Acad Dermatol 2000; 43: 918-9.
48. Azfar NA, Zaman T, Khan AR, Jahangir M. Scleromyxedema in an HCV-positive male. J Pak Assoc Dermatol 2008; 18: 116-8.
49. Rongioletti F, Rebora A. Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C. J Am Acad Dermatol 1998; 38: 760-1. (Pubitemid 28213721)
50. Shook BA, Wells MJ, Rapini RP, Cobos E. Epidermolysis bullosa acquisita occurring in 2 patients with hepatitis C. J Am Acad Dermatol 2006; 54: 888-91.